Literature DB >> 9241492

Epidemiology and relative toxicity of antidepressant drugs in overdose.

J A Henry1.   

Abstract

Antidepressant drugs are currently the mainstay of treatment for all but the mildest forms of depression. Their effectiveness in the management of depressive illness is undisputed and their effectiveness in preventing suicide, while not proven, may be assumed. Nevertheless, of all the drugs that are taken in lethal overdose, prescribed antidepressants are among the most common. Epidemiological studies from several countries have provided evidence of marked differences in overdose toxicity between drug classes and, in some cases, between individual drugs within a class, with some of the older tricyclic antidepressants (TCAs) being the most toxic. Over 80% of all deaths arising from overdose of antidepressant medication in the UK between 1987 and 1992 were caused by 2 drugs: amitriptyline and dothiepin. Taken alone, this figure conveys little information about the toxicity of either drug. However, when considered within an epidemiological context, the evidence suggests that both drugs are highly toxic in overdose, a conclusion that is supported by animal studies of the toxicity of TCAs and by clinical evidence of overdose toxicity. This paper reviews the epidemiological evidence concerning the acute toxicity of antidepressant drugs and considers the interplay of factors that contribute to the toxicity which occurs when they are taken in acute overdose. The inherent toxicity of the drug appears to be the crucial factor and, although less well researched, prescribing practices and perception of toxicity are probable contributory factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241492     DOI: 10.2165/00002018-199716060-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  79 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

Review 2.  Antidepressants and suicide risk: issues of chemical and behavioral toxicity.

Authors:  A Molcho; M Stanley
Journal:  J Clin Psychopharmacol       Date:  1992-04       Impact factor: 3.153

3.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

4.  Toxicity of dothiepin in overdose.

Authors:  H McGrady; J A Rees
Journal:  Lancet       Date:  1994-01-29       Impact factor: 79.321

5.  Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology.

Authors:  S A Montgomery; P Bebbington; P Cowen; W Deakin; P Freeling; C Hallstrom; C Katona; D King; B Leonard; S Levine; A Phanjoo; M Peet; C Thompson
Journal:  J Psychopharmacol       Date:  1993-01       Impact factor: 4.153

6.  Paradoxical worsening of depressive symptomatology caused by antidepressants.

Authors:  N F Damluji; J M Ferguson
Journal:  J Clin Psychopharmacol       Date:  1988-10       Impact factor: 3.153

7.  Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Authors:  F Song; N Freemantle; T A Sheldon; A House; P Watson; A Long; J Mason
Journal:  BMJ       Date:  1993-03-13

Review 8.  Antidepressant drug therapy: associated risks.

Authors:  R Amrein; S R Allen; D Vranesic; M Stabl
Journal:  J Neural Transm Suppl       Date:  1988

9.  Antidepressants and suicide.

Authors:  S S Jick; A D Dean; H Jick
Journal:  BMJ       Date:  1995-01-28

10.  Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.

Authors:  N A Buckley; A H Dawson; I M Whyte; D A Henry
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

View more
  16 in total

1.  Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.

Authors:  A G Teschemacher; E P Seward; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

2.  New antidepressants for old people?

Authors:  M G Livingston; H M Livingston
Journal:  BMJ       Date:  1999-06-19

3.  Overdose risk with selective serotonin reuptake inhibitors.

Authors:  C Muldoon
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 4.  Suicidality with selective serotonin reuptake inhibitors: Valid claim?

Authors:  Yvon D Lapierre
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 5.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Acute poisoning: understanding 90% of cases in a nutshell.

Authors:  S L Greene; P I Dargan; A L Jones
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

Review 7.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 8.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

9.  Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data?

Authors:  N A Buckley; P R McManus
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

10.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.

Authors:  James T Milnes; Olivia Crociani; Annarosa Arcangeli; Jules C Hancox; Harry J Witchel
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.